Lung Allograft Rejection

被引:8
作者
Levine, Deborah J. [1 ]
Hachem, Ramsey R. [2 ]
机构
[1] Univ Texas Hlth San Antonio, Div Pulm & Crit Care Med, 7703 Floyd Curl Dr, San Antonio, TX 78229 USA
[2] Washington Univ, Div Pulm & Crit Care Med, 4523 Clayton Ave,Mailstop 8052-0043-14, St Louis, MO 63110 USA
关键词
Lung transplantation; Acute cellular rejection; Antibody-mediated rejection; Donor-specific antibodies; ANTIBODY-MEDIATED REJECTION; ACUTE CELLULAR REJECTION; BRONCHIOLITIS OBLITERANS SYNDROME; REFRACTORY ACUTE REJECTION; DONOR-SPECIFIC ANTIBODIES; HLA-SPECIFIC ANTIBODIES; HYPERACUTE REJECTION; CONTROLLED-TRIAL; PLASMA-EXCHANGE; HEART-LUNG;
D O I
10.1016/j.thorsurg.2021.12.003
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Rejection is a major complication following lung transplantation. Acute cellular rejection (ACR), and antibody-mediated rejection (AMR) are risk factors for the subsequent development of chronic lung allograft dysfunction and worse outcomes after transplantation. Although ACR has well-defined histopathologic diagnostic criteria and grading, the diagnosis of AMR requires a multidisciplinary diagnostic approach. This article reviews the identification, clinical and pathologic features of, and therapeutic options for ACR and AMR. Copyright © 2021 Elsevier Inc. All rights reserved.
引用
收藏
页码:221 / 229
页数:9
相关论文
共 68 条
[1]   Donor-derived cell-free DNA predicts allograft failure and mortality after lung transplantation [J].
Agbor-Enoh, Sean ;
Wang, Yan ;
Tunc, Ilker ;
Jang, Moon Kyoo ;
Davis, Andrew ;
De Vlaminck, Iwijn ;
Luikart, Helen ;
Shah, Pali D. ;
Timofte, Irina ;
Brown, Anne W. ;
Marishta, Argit ;
Bhatti, Kenneth ;
Gorham, Sasha ;
Fideli, Ulgen ;
Wylie, Jennifer ;
Grimm, David ;
Goodwin, Natalie ;
Yang, Yanqin ;
Patel, Kapil ;
Zhu, Jun ;
Laconoad, Aldo ;
Orens, Jonathan B. ;
Nathan, Steven D. ;
Marboe, Charles ;
Berry, Gerald J. ;
Quake, Stephen R. ;
Khush, Kiran ;
Valantine, Hannah A. .
EBIOMEDICINE, 2019, 40 :541-553
[2]   Late manifestation of alloantibody-associated injury and clinical pulmonary antibody-mediated rejection: Evidence from cell-free DNA analysis [J].
Agbor-Enoh, Sean ;
Jackson, Annette M. ;
Tunc, Ilker ;
Berry, Gerald J. ;
Cochrane, Adam ;
Grimm, David ;
Davis, Andrew ;
Shah, Pali ;
Brown, Anne W. ;
Wang, Yan ;
Timofte, Irina ;
Shah, Palak ;
Gorham, Sasha ;
Wylie, Jennifer ;
Goodwin, Natalie ;
Jang, Moon Kyoo ;
Marishta, Argit ;
Bhatti, Kenneth ;
Fideli, Ulgen ;
Yang, Yanqin ;
Luikart, Helen ;
Cao, Zeling ;
Pirooznia, Mehdi ;
Zhu, Jun ;
Marboe, Charles ;
Iacono, Aldo ;
Nathan, Steven D. ;
Orens, Jonathan ;
Valantine, Hannah A. ;
Khush, Kiran .
JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2018, 37 (07) :925-932
[3]   The role of C4d deposition in the diagnosis of antibody-mediated rejection after lung transplantation [J].
Aguilar, P. R. ;
Carpenter, D. ;
Ritter, J. ;
Yusen, R. D. ;
Witt, C. A. ;
Byers, D. E. ;
Mohanakumar, T. ;
Kreisel, D. ;
Trulock, E. P. ;
Hachem, R. R. .
AMERICAN JOURNAL OF TRANSPLANTATION, 2018, 18 (04) :936-944
[4]   PLASMA-EXCHANGE IN ACUTE RENAL-ALLOGRAFT REJECTION - A CONTROLLED TRIAL [J].
ALLEN, NH ;
DYER, P ;
GEOGHEGAN, T ;
HARRIS, K ;
LEE, HA ;
SLAPAK, M .
TRANSPLANTATION, 1983, 35 (05) :425-428
[5]   ANALYSIS OF TIME-DEPENDENT RISKS FOR INFECTION, REJECTION, AND DEATH AFTER PULMONARY TRANSPLANTATION [J].
BANDO, K ;
PARADIS, IL ;
KOMATSU, K ;
KONISHI, H ;
MATSUSHIMA, M ;
KEENAN, RJ ;
HARDESTY, RL ;
ARMITAGE, JM ;
GRIFFITH, BP .
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 1995, 109 (01) :49-59
[6]   Pathology of pulmonary antibody-mediated rejection: 2012 update from the Pathology Council of the ISHLT [J].
Berry, Gerald ;
Burke, Margaret ;
Andersen, Claus ;
Angelini, Annalisa ;
Bruneval, Patrick ;
Calbrese, Fiorella ;
Fishbein, Michael C. ;
Goddard, Martin ;
Leone, Ornella ;
Maleszewski, Joseph ;
Marboe, Charles ;
Miller, Dylan ;
Neil, Desley ;
Padera, Robert ;
Rassi, Doris ;
Revell, Monica ;
Rice, Alexandra ;
Stewart, Susan ;
Yousem, Samuel A. .
JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2013, 32 (01) :14-21
[7]   Hyperacute rejection in single lung transplantation-case report of successful management by means of plasmapheresis and antithymocyte globulin treatment [J].
Bittner, HB ;
Dunitz, J ;
Hertz, M ;
Bolman, MR ;
Park, SJ .
TRANSPLANTATION, 2001, 71 (05) :649-651
[8]  
BLAKE P, 1990, PROG CLIN BIOL RES, P249
[9]  
Bonomini V, 1985, Trans Am Soc Artif Intern Organs, V31, P698
[10]   Acute Cellular Rejection Is a Risk Factor for Bronchiolitis Obliterans Syndrome Independent of Post-transplant Baseline FEV1 [J].
Burton, Christopher M. ;
Iversen, Martin ;
Carlsen, Jorn ;
Mortensen, Jann ;
Andersen, Claus B. ;
Steinbruchel, Daniel ;
Scheike, Thomas .
JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2009, 28 (09) :888-893